Financial Consulate, Inc Aerie Pharmaceuticals Inc Transaction History

Financial Consulate, Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 29, 2021	SELL	$9.12 - $14.49 $95,759 - $152,145	-10,500 Closed	0 $0
Q4 2017 Jan 29, 2018	SELL	$50.85 - $65.1 $406,800 - $520,799	-8,000 Reduced 43.24%	10,500 $627,000
Q3 2017 Oct 19, 2017	BUY	$48.6 - $60.1 $899,100 - $1.11 Million	18,500	18,500 $899,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Financial Consulate, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Consulate, Inc with notifications on news.